GLP-1/GIP dual agonist, preparation method and use thereof
Grant
US12589158B2
Kind: B2
Mar 31, 2026
Assignee
Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd.
Inventors
Nan Zhang, Chunhua Jiang, Dongzhou Liu, Li Teng, Jiale Shen
Abstract
The present invention relates to long-acting GLP-1/GIP dual agonist compounds having a dual agonistic effect on glucagon-like peptide-1 (GLP-1) receptor and human glucose-dependent insulinotropic polypeptide (GIP) receptor. The present invention also relates to the use of said compounds in the manufacture of medicaments for treating Type II diabetes mellitus.
CPC Classifications
A61K 47/64
A61P 3/04
A61P 3/10
C07K 14/605
Filing Date
2024-03-12
Application No.
18602255
Claims
2